Smoldering myeloma: Difference between revisions
From IDWiki
(Imported from text file) Â |
(→â€)  |
||
| Line 1: | Line 1: | ||
| − | == |
+ | ==Definition== |
| − | * |
+ | *M-spike ≥30 g/L or UPEP ≥500 mg/24h, and/or |
| − | * |
+ | *Bone marrow plasma cells 10-60%, and |
| − | * |
+ | *No end-organ damage |
| − | == |
+ | == Management == |
| + | |||
| ⚫ | |||
| + | * Monitoring |
||
| + | |||
| + | ==Prognosis== |
||
| + | |||
| ⚫ | |||
[[Category:Hematology]] |
[[Category:Hematology]] |
||
Latest revision as of 16:05, 2 August 2020
Definition
- M-spike ≥30 g/L or UPEP ≥500 mg/24h, and/or
- Bone marrow plasma cells 10-60%, and
- No end-organ damage
Management
- Monitoring
Prognosis
- About 10% per year will progress to multiple myeloma
